ملائیشین جینومکس ریسورس سنٹر نئے وینچر کے ذریعے کلیدی ہولیسٹک رینل کیئر پیش کرے گا

PETALING JAYA, Malaysia, Jun 23, 2022 – (ACN Newswire) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Group is acquiring a 51% stake in Aquahealth Sdn Bhd, a kidney dialysis operator, from Rinani Renal Berhad.

Aquahealth ملائیشیا انٹرنیشنل اسلامک چیمبر آف کامرس کی ملکیت والے مرکز کو چلانے کے لائسنس کے ساتھ، گومباک، سیلنگور میں گردے کا ڈائیلاسز سینٹر قائم کر رہا ہے۔ حصص کے حصول کے ساتھ، ملائیشین جینومکس، اپنی مکمل ملکیتی ذیلی کمپنی، MGRC ہیلتھ کیئر Sdn Bhd کے ذریعے، اب ڈائیلاسز سنٹر کا آپریٹر بن جائے گا۔

En. Sasha Nordin, Chief Executive Officer of Malaysian Genomics, said, "This will be the first of many centres across the country that will be driven by a personalised kidney care model integrating dialysis with nutrition management, lifestyle changes, and even genetic testing of patients and their immediate family members. This pioneering approach will focus on bringing innovations in service delivery to improve the lives of patients with chronic kidney disease."

"Expanding downstream to healthcare services, through our subsidiary MGRC Healthcare, is an important step in Malaysian Genomics' growth as a diversified specialist healthcare group. The acquisition of the Aquahealth stake is part of our Group's strategy to secure a diverse portfolio of earnings accretive assets across Southeast Asia that will, in turn, leverage and benefit from our genomics and biopharmaceutical knowledge and experience developed over the past 18 years."

According to the Ministry of Health's Management of Chronic Kidney Disease report, the number of Malaysians with kidney disease is projected to increase significantly in the future mainly due to the prevalence of diabetes, hypertension and an aging population[1]. At 13.2% per year, Malaysia has the second highest annual growth rate of chronic kidney disease in the world[2].

Dato' Dr. Suhaini Kadiman, Chairman of Malaysia International Islamic Chamber of Commerce and Director of Clinical Research at Institute Jantung Negara added, "Thousands of kidney patients are on waiting lists for dialysis treatment and new centres are urgently needed. We welcome MGRC Healthcare's interest to collaborate with us to operate the centre in Gombak, and we look forward to the innovations they will contribute to improve the lives of kidney dialysis patients."

حال ہی میں، وزیر صحت YB Tuan خیری جمال الدین نے نوٹ کیا کہ ملائیشیا میں گردے کے 40,000 سے زیادہ مریض ہیں، جن میں 8,000 سے سالانہ 2018 نئے مریضوں کی تشخیص ہوتی ہے[3]۔

ہے [1] https://tinyurl.com/42jexjsk
ہے [2] https://tinyurl.com/2cmkmzkz
ہے [3] https://tinyurl.com/mr3mkfmk

ملائیشین جینومکس ریسورس سینٹر برہاد: 0155 [برسا: MGRC] [RIC: MGRC:KL] [BBG: MGRC:MK]، http://www.mgrc.com.my/

Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comMalaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Group is acquiring a 51% stake in Aquahealth Sdn Bhd, a kidney dialysis operator, from Rinani Renal Berhad.

• سکے سمارٹ۔ یورپ کا بہترین بٹ کوائن اور کرپٹو ایکسچینج۔
• پلیٹو بلاک چین۔ Web3 Metaverse انٹیلی جنس۔ علم میں اضافہ۔ مفت رسائی۔
• کرپٹو ہاک۔ Altcoin ریڈار. مفت جانچ.
• ماخذ: https://www.acnnewswire.com/press-release/english/76040/